DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Hammers HJ, Plimack ER, Infante JR. et al.
Safety and efficacy of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma: The CheckMate 016 Study.
J Clin Oncol 2017;
35: 38513858
We do not assume any responsibility for the contents of the web pages of other providers.